Company / PP&E (Net)
BioNexus Gene Lab Corp PP&E (Net) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$1.6M
FY2025
5-year range
$1.5M / $1.6M
FY2021-FY2025
Trend
+5.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -2.2%.
Improved from $2M to $2M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +1.9%
- 5-Year CAGR
- -2.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -2.2%, indicating a declining trend.
- In FY2025, pp&e (net) increased 5.0% year-over-year.
- Peak pp&e (net) was recorded in FY2020.
- Lowest pp&e (net) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.6M | +5.0% |
| FY2024 | $1.5M | +0.8% |
| FY2023 | $1.5M | -0.0% |
| FY2022 | $1.5M | -7.5% |
| FY2021 | $1.6M | -8.5% |
| FY2020 | $1.8M | +470.6% |
| FY2019 | $312.9K | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026